Phreesia (NYSE:PHR) Stock Rating Upgraded by Wall Street Zen

Phreesia (NYSE:PHR - Get Free Report) was upgraded by investment analysts at Wall Street Zen from a "hold" rating to a "buy" rating in a research note issued on Sunday.

Other analysts have also issued reports about the company. DA Davidson cut their price target on Phreesia from $36.00 to $34.00 and set a "buy" rating on the stock in a research note on Monday, April 14th. Truist Financial increased their target price on shares of Phreesia from $34.00 to $35.00 and gave the stock a "buy" rating in a research note on Thursday, May 29th. Canaccord Genuity Group decreased their price objective on Phreesia from $35.00 to $34.00 and set a "buy" rating for the company in a report on Thursday, May 29th. Needham & Company LLC restated a "buy" rating and issued a $29.00 target price on shares of Phreesia in a research note on Thursday, March 13th. Finally, Citigroup reissued a "buy" rating on shares of Phreesia in a report on Wednesday, May 28th. Twelve research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, Phreesia currently has a consensus rating of "Buy" and a consensus price target of $31.64.

Phreesia Price Performance

Phreesia stock traded down $0.54 during mid-day trading on Friday, reaching $25.24. 393,591 shares of the company were exchanged, compared to its average volume of 439,359. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.74 and a quick ratio of 1.74. Phreesia has a 12 month low of $17.07 and a 12 month high of $30.53. The firm has a market cap of $1.50 billion, a PE ratio of -17.17 and a beta of 0.74. The company has a fifty day simple moving average of $24.72 and a 200-day simple moving average of $25.36.

Phreesia (NYSE:PHR - Get Free Report) last issued its earnings results on Wednesday, May 28th. The company reported ($0.07) earnings per share for the quarter, beating analysts' consensus estimates of ($0.13) by $0.06. The firm had revenue of $115.94 million for the quarter, compared to the consensus estimate of $115.00 million. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The company's revenue was up 14.5% compared to the same quarter last year. During the same quarter last year, the business posted ($0.05) EPS. As a group, equities research analysts expect that Phreesia will post -1.1 earnings per share for the current fiscal year.

Insider Activity

In other news, General Counsel Allison C. Hoffman sold 1,213 shares of the stock in a transaction on Wednesday, April 16th. The shares were sold at an average price of $23.81, for a total value of $28,881.53. Following the transaction, the general counsel now owns 137,921 shares of the company's stock, valued at $3,283,899.01. This represents a 0.87% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, SVP David Linetsky sold 3,944 shares of the firm's stock in a transaction dated Tuesday, April 8th. The shares were sold at an average price of $23.85, for a total value of $94,064.40. Following the sale, the senior vice president now owns 221,738 shares in the company, valued at $5,288,451.30. The trade was a 1.75% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 42,474 shares of company stock worth $1,023,208. 5.50% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several large investors have recently made changes to their positions in the business. Johnson Financial Group Inc. lifted its stake in shares of Phreesia by 381.3% in the 4th quarter. Johnson Financial Group Inc. now owns 1,131 shares of the company's stock valued at $28,000 after acquiring an additional 896 shares during the last quarter. R Squared Ltd purchased a new stake in Phreesia in the fourth quarter worth $30,000. BankPlus Trust Department purchased a new stake in shares of Phreesia in the 4th quarter worth about $34,000. Quarry LP increased its stake in shares of Phreesia by 210.9% during the fourth quarter. Quarry LP now owns 2,835 shares of the company's stock valued at $71,000 after purchasing an additional 1,923 shares in the last quarter. Finally, KBC Group NV purchased a new position in Phreesia during the first quarter valued at $74,000. 92.10% of the stock is owned by hedge funds and other institutional investors.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.